MIRALAX 8.3 OZ Recalled Due to Improper Storage Temperature Conditions
Family Dollar Stores is recalling MIRALAX 8.3 OZ (SKU 902219) distributed nationwide from April 30 to June 10, 2022. The product was held outside appropriate storage temperatures, violating manufacturing standards.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification indicates potential harm to a drug product. Storage temperature deviations present a risk-of-harm situation through potential compromise of drug efficacy and safety. This aligns with the rubric criterion for Score 3: risk-of-harm products where injury has not yet been reported.
Plain-English summary
Family Dollar Stores, LLC is recalling MIRALAX 8.3 OZ that was distributed to select Family Dollar locations nationwide from April 30, 2022, through June 10, 2022. The affected product has SKU 902219.
The recall was issued because the product was held outside appropriate storage temperature conditions, constituting a deviation from Good Manufacturing Practice (CGMP) standards.
Consumers who have purchased this product should stop use and dispose of it appropriately. For additional information or questions, consumers may contact their local Family Dollar store.
The recalled product
- Product
- MIRALAX 8.3 OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 902219
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27